Correct usage and dosage of dacomitinib/dacomitinib, and how to use it?

Dacomitinib is a kinase inhibitor for epidermal growth factor receptor (EGFR pan>) First-line treatment of patients with metastatic non-small cell lung cancer who have exon 19 deletions or exon 21 substitution mutations.

Dacomitinib/Instructions for DacomitinibThe recommended dose is 45 mg once daily, each time with or without food until unacceptable toxicity occurs in the disease. Dacomitinib/Dacomitinib is an oral tablet. It is usually taken once daily, with or without food. Take dacomitinib/dacomitinib at about the same time each day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you don't understand. Take dacomitinib/dacomitinib exactly as directed. Do not take too much or too little or more often than prescribed by your doctor. If you vomit after taking dacomitinib/dacomitinib, do not take another dose right away. Continue regular dosing schedule. If certain side effects of dacomitinib/dacomitinib occur, your doctor may temporarily or permanently stop treatment or reduce the dose. If you are pregnant or plan to become pregnant, tell your doctor. Before starting treatment, a pregnancy test must be taken. You should not become pregnant while taking dacomitinib. A reliable method of contraception should be used while taking dacomitinib and for at least 17 days after the last dose. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.